Open-label trial in Japan, 2216 patients with STEMI: low-dose prasugrel alone was not noninferior to prasugrel plus aspirin for death, stroke or MI at 12 months (estimated 11.0% vs 8.5%; HR 1.34). Major bleeding was lower: 5.6% vs 8.4%.
RCTn = 2,216
Takahashi et al. Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI